Viridian Therapeutics
VRDN
VRDN
176 hedge funds and large institutions have $1.23B invested in Viridian Therapeutics in 2025 Q1 according to their latest regulatory filings, with 26 funds opening new positions, 67 increasing their positions, 55 reducing their positions, and 27 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
2.82% less ownership
Funds ownership: 114.94% → 112.12% (-2.8%)
29% less capital invested
Capital invested by funds: $1.75B → $1.23B (-$514M)
33% less funds holding in top 10
Funds holding in top 10: 12 → 8 (-4)
Holders
176
Holding in Top 10
8
Calls
$1.85M
Puts
$941K
Top Buyers
| 1 | +$18.5M | |
| 2 | +$16.2M | |
| 3 | +$14.6M | |
| 4 |
DTC
Deep Track Capital
Greenwich,
Connecticut
|
+$11.6M |
| 5 |
EP
Eversept Partners
New York
|
+$8.06M |
Top Sellers
| 1 | -$12.1M | |
| 2 | -$11.1M | |
| 3 | -$8.86M | |
| 4 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$8.81M |
| 5 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
-$8.16M |
